Systematic Review Examines AI's Role in Chemotherapy Regimen Selection
AI-Assisted Chemotherapy Regimen Selection Under Review
A new systematic review published in Cureus examines the use of artificial intelligence in selecting chemotherapy regimens and the resulting effects on clinical outcomes and adverse drug reactions. The review synthesizes existing evidence on how AI systems are being integrated into oncology treatment planning.
Key Focus Areas
The review evaluates AI-assisted approaches across several dimensions:
- Treatment Selection Accuracy: How well AI systems recommend appropriate chemotherapy regimens compared to standard clinical decision-making
- Clinical Outcomes: Patient responses and survival rates when AI-assisted regimens are used
- Adverse Drug Reactions: The impact of AI recommendations on the frequency and severity of side effects
Significance
As oncology treatment becomes increasingly complex, AI systems are being developed to help clinicians navigate the growing number of chemotherapy options and patient variables. This systematic review provides a comprehensive look at the current evidence base for such applications.